Hydroxycarboxylic acid receptor 2
Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5- methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid > acifran > 5-methyl nicotinic acid = acipimox >> nicotinuric acid = nicotinamide.
Database | Links |
---|---|
UniProt | Q8TDS4 |
PDB | Not available |
BioGrid | Not available |
BindingDB | Q8TDS4 |
DrugBank | DB04843, DB00627 |
Guide to PHARMACOLOGY | 312 |
PharmGKB | PA165961843 |
KEGG | hsa:338442 |
BioCyc | Not available |
Entrez Gene (GeneID) | 338442 |
Metric | Mean Value | Standard Deviation |
---|---|---|
AUC | 0.9621 | 0.0017 |
Accuracy | 0.9136 | 0.0029 |
Sensitivity | 0.9473 | 0.0046 |
Specificity | 0.8747 | 0.0055 |
BEDROC | 0.9572 | 0.0124 |
MCC Threshold | 0.366 | N/A |
MCC | 0.8356 | N/A |
F-score Threshold | 0.366 | N/A |
F-score | 0.9255 | N/A |